Group I (n = 36) | Group II (n = 73) | P value | |
---|---|---|---|
Successful implantation, n (%) | 36 (100.0%) | 73 (100.0%) | 1.000 |
TEE measure | |||
LAA ostium width, mm (mean ± SD) | 22.08 ± 3.80 | 22.16 ± 3.76 | 0.915 |
LAA length, mm (mean ± SD) | 27. 03 ± 4.66 | 25.67 ± 4.49 | 0.136 |
DSA measure | |||
LAA ostium width, mm (mean ± SD) | 21.89 ± 4.49 | 22.49 ± 4.10 | 0.642 |
LAA length, mm (mean ± SD) | 24.86 ± 4.77 | 25.34 ± 4.85 | 0.502 |
Type of LAAC device, each n (%) | |||
Watchman™ | 33 (91.7%) | 68 (93.2%) | 1.000 |
LAmbre™ | 1 (2.8%) | 4 (5.4%) | 0.883 |
Leftear™ | 2 (5.5%) | 1 (1.4%) | 0.526 |
No peri-device leak, n (%) | 34 (94.4%) | 61 (83.6%) | 0.196 |
Peri-device leak < 5 mm, n (%) | 2 (5.6%) | 12 (16.4%) | 0.196 |
Peri-device leak ≥ 5 mm, n (%) | 0 (0%) | 0 (0%) | 1.000 |
Pericardial effusion (< 3 mm), n (%) | 2 (5.6%) | 4 (5.5%) | 1.000 |
ACT, s (mean ± SD) | 269.18 ± 37.53 | 256.51 ± 43.06 | 0.087 |
Number of implantation attempts (mean ± SD) | 1.19 ± 0.52 | 1.34 ± 0.77 | 0.223 |
Procedure Time, min (mean ± SD) | 62.25 ± 23.16 | 69.59 ± 33.22 | 0.450 |
Peri-procedural complications | |||
Death, n (%) | 0 (0%) | 0 (0%) | 1.000 |
Stroke, n (%) | 0 (0%) | 0 (0%) | 1.000 |
Major Bleeding, n (%) | 0 (0%) | 0 (0%) | 1.000 |
DRT, n (%) | 0 (0%) | 0 (0%) | 1.000 |
Cardiac tamponade, n (%) | 0 (0%) | 1 (1.4%) | 1.000 |
Pericardial effusion with conservative treatment, n (%) | 2 (5.6%) | 4 (5.5%) | 1.000 |
Severe vascular complication, n (%) | 0 (0%) | 1 (1.4%) | 1.000 |
Hypotension, n (%) | 1 (2.8%) | 0 (0%) | 0.327 |